Abstract
Infantile colic, constipation, functional abdominal pain (FAP), and irritable bowel syndrome (IBS) are the most common functional gastrointestinal disorders (FGID). This chapter will review current evidence on the role of probiotics in the treatment of these FGID. The etiology of FGID is considered multifactorial, but the importance of intestinal microbiota in their development has been repeatedly emphasized. As a consequence, the potential role of probiotics in their treatment is being increasingly scrutinized. Presently, the strongest evidence of efficacy is for the use of Lactobacillus reuteri (L reuteri) DSM 17938 at the dose of 108 CFU/day for the treatment of infantile colic in breastfed infants. Limited, yet encouraging, evidence exists for Lactobacillus rhamnosus GG (LGG) at the dose of 3 × 109 CFU and for a multi-strain preparation for the treatment of IBS. In the treatment of FAP, there is some evidence for the use of L reuteri DSM 17938 at the dose of at least 108 CFU/day.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abbott RA, Martin AE, Newlove-Delgado TV, Bethel A, Whear RS, Coon JT, Logan S (2018) Recurrent abdominal pain in children: summary evidence from 3 systematic reviews of treatment effectiveness. J Pediatr Gastroenterol Nutr 67:23. https://doi.org/10.1097/MPG.0000000000001922
Anabrees J, Indrio F, Paes B, AlFaleh K (2013) Probiotics for infantile colic: a systematic review. BMC Pediatr 13:186. https://doi.org/10.1186/1471-2431-13-186
Assa A, Ish-Tov A, Rinawi F, Shamir R (2015) School attendance in children with functional abdominal pain and inflammatory bowel diseases. J Pediatr Gastroenterol Nutr 61(5):553–557. https://doi.org/10.1097/MPG.0000000000000850
Attaluri A, Jackson M, Valestin J, Rao SS (2010) Methanogenic flora is associated with altered colonic transit but not stool characteristics in constipation without IBS. Am J Gastroenterol 105(6):1407–1411. https://doi.org/10.1038/ajg.2009.655
Banaszkiewicz A, Szajewska H (2005) Ineffectiveness of Lactobacillus GG as an adjunct to lactulose for the treatment of constipation in children: a double-blind, placebo-controlled randomized trial. J Pediatr 146(3):364–369. https://doi.org/10.1016/j.jpeds.2004.10.022
Bar F, Von Koschitzky H, Roblick U, Bruch HP, Schulze L, Sonnenborn U, Bottner M, Wedel T (2009) Cell-free supernatants of Escherichia coli Nissle 1917 modulate human colonic motility: evidence from an in vitro organ bath study. Neurogastroenterol Motil 21(5):559–566, e516–557. https://doi.org/10.1111/j.1365-2982.2008.01258.x
Bauserman M, Michail S (2005) The use of Lactobacillus GG in irritable bowel syndrome in children: a double-blind randomized control trial. J Pediatr 147(2):197–201. https://doi.org/10.1016/j.jpeds.2005.05.015
Benninga MA, Voskuijl WP, Taminiau JA (2004) Childhood constipation: is there new light in the tunnel? J Pediatr Gastroenterol Nutr 39(5):448–464
Benninga MA, Faure C, Hyman PE, St James Roberts I, Schechter NL, Nurko S (2016) Childhood functional gastrointestinal disorders: neonate/toddler. Gastroenterology 150:1443. https://doi.org/10.1053/j.gastro.2016.02.016
Biagioli E, Tarasco V, Lingua C, Moja L, Savino F (2016) Pain-relieving agents for infantile colic. Cochrane Database Syst Rev 9:CD009999. https://doi.org/10.1002/14651858.CD009999.pub2
Bonilla S, Saps M (2013) Early life events predispose the onset of childhood functional gastrointestinal disorders. Rev Gastroenterol Mex 78(2):82–91. https://doi.org/10.1016/j.rgmx.2013.02.001
Bouhnik Y, Neut C, Raskine L, Michel C, Riottot M, Andrieux C, Guillemot F, Dyard F, Flourie B (2004) Prospective, randomized, parallel-group trial to evaluate the effects of lactulose and polyethylene glycol-4000 on colonic flora in chronic idiopathic constipation. Aliment Pharmacol Ther 19(8):889–899. https://doi.org/10.1111/j.1365-2036.2004.01918.x
Bu LN, Chang MH, Ni YH, Chen HL, Cheng CC (2007) Lactobacillus casei rhamnosus Lcr35 in children with chronic constipation. Pediatr Int 49(4):485–490. https://doi.org/10.1111/j.1442-200X.2007.02397.x
Chau K, Lau E, Greenberg S, Jacobson S, Yazdani-Brojeni P, Verma N, Koren G (2015) Probiotics for infantile colic: a randomized, double-blind, placebo-controlled trial investigating Lactobacillus reuteri DSM 17938. J Pediatr 166(1):74–78. https://doi.org/10.1016/j.jpeds.2014.09.020
Chumpitazi BP, Cope JL, Hollister EB, Tsai CM, McMeans AR, Luna RA, Versalovic J, Shulman RJ (2015) Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. Aliment Pharmacol Ther 42(4):418–427. https://doi.org/10.1111/apt.13286
Coccorullo P, Strisciuglio C, Martinelli M, Miele E, Greco L, Staiano A (2010) Lactobacillus reuteri (DSM 17938) in infants with functional chronic constipation: a double-blind, randomized, placebo-controlled study. J Pediatr 157(4):598–602. https://doi.org/10.1016/j.jpeds.2010.04.066
de Meij TG, de Groot EF, Eck A, Budding AE, Kneepkens CM, Benninga MA, van Bodegraven AA, Savelkoul PH (2016) Characterization of microbiota in children with chronic functional constipation. PLoS One 11(10):e0164731. https://doi.org/10.1371/journal.pone.0164731
de Weerth C, Fuentes S, Puylaert P, de Vos WM (2013) Intestinal microbiota of infants with colic: development and specific signatures. Pediatrics 131(2):e550–e558. https://doi.org/10.1542/peds.2012-1449
Dimidi E, Christodoulides S, Fragkos KC, Scott SM, Whelan K (2014) The effect of probiotics on functional constipation in adults: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr 100(4):1075–1084. https://doi.org/10.3945/ajcn.114.089151
Dimidi E, Christodoulides S, Scott SM, Whelan K (2017) Mechanisms of action of probiotics and the gastrointestinal microbiota on gut motility and constipation. Adv Nutr 8(3):484–494. https://doi.org/10.3945/an.116.014407
Dubois NE, Gregory KE (2016) Characterizing the intestinal microbiome in infantile colic: findings based on an integrative review of the literature. Biol Res Nurs 18(3):307–315. https://doi.org/10.1177/1099800415620840
Eftekhari K, Vahedi Z, Kamali Aghdam M, Noemi Diaz D (2015) A randomized double-blind placebo-controlled trial of lactobacillus reuteri for chronic functional abdominal pain in children. Iran J Pediatr 25(6):e2616. https://doi.org/10.5812/ijp.2616
Faure C, Wieckowska A (2007) Somatic referral of visceral sensations and rectal sensory threshold for pain in children with functional gastrointestinal disorders. J Pediatr 150(1):66–71. https://doi.org/10.1016/j.jpeds.2006.08.072
Francavilla R, Miniello V, Magista AM, De Canio A, Bucci N, Gagliardi F, Lionetti E, Castellaneta S, Polimeno L, Peccarisi L, Indrio F, Cavallo L (2010) A randomized controlled trial of Lactobacillus GG in children with functional abdominal pain. Pediatrics 126(6):e1445–e1452. https://doi.org/10.1542/peds.2010-0467
Gawronska A, Dziechciarz P, Horvath A, Szajewska H (2007) A randomized double-blind placebo-controlled trial of Lactobacillus GG for abdominal pain disorders in children. Aliment Pharmacol Ther 25(2):177–184. https://doi.org/10.1111/j.1365-2036.2006.03175.x
Giannetti E, Staiano A (2016) Probiotics for irritable bowel syndrome: clinical data in children. J Pediatr Gastroenterol Nutr 63(Suppl 1):S25–S26. https://doi.org/10.1097/MPG.0000000000001220
Giannetti E, Maglione M, Alessandrella A, Strisciuglio C, De Giovanni D, Campanozzi A, Miele E, Staiano A (2017) A mixture of 3 bifidobacteria decreases abdominal pain and improves the quality of life in children with irritable bowel syndrome: a multicenter, randomized, double-blind, placebo-controlled, crossover trial. J Clin Gastroenterol 51(1):e5–e10. https://doi.org/10.1097/MCG.0000000000000528
Guandalini S, Magazzu G, Chiaro A, La Balestra V, Di Nardo G, Gopalan S, Sibal A, Romano C, Canani RB, Lionetti P, Setty M (2010) VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study. J Pediatr Gastroenterol Nutr 51(1):24–30. https://doi.org/10.1097/MPG.0b013e3181ca4d95
Guerra PV, Lima LN, Souza TC, Mazochi V, Penna FJ, Silva AM, Nicoli JR, Guimaraes EV (2011) Pediatric functional constipation treatment with Bifidobacterium-containing yogurt: a crossover, double-blind, controlled trial. World J Gastroenterol 17(34):3916–3921. https://doi.org/10.3748/wjg.v17.i34.3916
Gutierrez-Castrellon P, Indrio F, Bolio-Galvis A, Jimenez-Gutierrez C, Jimenez-Escobar I, Lopez-Velazquez G (2017) Efficacy of lactobacillus reuteri DSM 17938 for infantile colic: systematic review with network meta-analysis. Medicine (Baltimore) 96(51):e9375. https://doi.org/10.1097/MD.0000000000009375
Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI (2001) Molecular analysis of commensal host-microbial relationships in the intestine. Science 291(5505):881–884. https://doi.org/10.1126/science.291.5505.881
Horvath A, Dziechciarz P, Szajewska H (2011) Meta-analysis: lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhood. Aliment Pharmacol Ther 33(12):1302–1310. https://doi.org/10.1111/j.1365-2036.2011.04665.x
Husebye E, Hellstrom PM, Sundler F, Chen J, Midtvedt T (2001) Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats. Am J Physiol Gastrointest Liver Physiol 280(3):G368–G380. https://doi.org/10.1152/ajpgi.2001.280.3.G368
Hyams JS, Di Lorenzo C, Saps M, Shulman RJ, Staiano A, van Tilburg M (2016) Functional disorders: children and adolescents. Gastroenterology 150:1456. https://doi.org/10.1053/j.gastro.2016.02.015
Indrio F, Di Mauro A, Riezzo G, Civardi E, Intini C, Corvaglia L, Ballardini E, Bisceglia M, Cinquetti M, Brazzoduro E, Del Vecchio A, Tafuri S, Francavilla R (2014) Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation: a randomized clinical trial. JAMA Pediatr 168(3):228–233. https://doi.org/10.1001/jamapediatrics.2013.4367
Jadresin O, Hojsak I, Misak Z, Kekez AJ, Trbojevic T, Ivkovic L, Kolacek S (2017) Lactobacillus reuteri DSM 17938 in the treatment of functional abdominal pain in children: RCT study. J Pediatr Gastroenterol Nutr 64(6):925–929. https://doi.org/10.1097/MPG.0000000000001478
Koppen IJN, Vriesman MH, Saps M, Rajindrajith S, Shi X, van Etten-Jamaludin FS, Di Lorenzo C, Benninga MA, Tabbers MM (2018) Prevalence of functional defecation disorders in children: a systematic review and meta-analysis. J Pediatr 198:121. https://doi.org/10.1016/j.jpeds.2018.02.029
Korterink J, Devanarayana NM, Rajindrajith S, Vlieger A, Benninga MA (2015) Childhood functional abdominal pain: mechanisms and management. Nat Rev Gastroenterol Hepatol 12(3):159–171. https://doi.org/10.1038/nrgastro.2015.21
Landgren K, Hallstrom I (2011) Parents’ experience of living with a baby with infantile colic – a phenomenological hermeneutic study. Scand J Caring Sci 25(2):317–324. https://doi.org/10.1111/j.1471-6712.2010.00829.x
Liu HN, Wu H, Chen YZ, Chen YJ, Shen XZ, Liu TT (2017) Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: a systematic review and meta-analysis. Dig Liver Dis 49(4):331–337. https://doi.org/10.1016/j.dld.2017.01.142
Lucassen P (2015) Colic in infants. BMJ Clin Evid 2015:pii: 0309
Maragkoudaki M, Chouliaras G, Orel R, Horvath A, Szajewska H, Papadopoulou A (2017) Lactobacillus reuteri DSM 17938 and a placebo both significantly reduced symptoms in children with functional abdominal pain. Acta Paediatr 106(11):1857–1862. https://doi.org/10.1111/apa.13992
Mi GL, Zhao L, Qiao DD, Kang WQ, Tang MQ, Xu JK (2015) Effectiveness of Lactobacillus reuteri in infantile colic and colicky induced maternal depression: a prospective single blind randomized trial. Antonie Van Leeuwenhoek 107(6):1547–1553. https://doi.org/10.1007/s10482-015-0448-9
Ohman L, Simren M (2013) Intestinal microbiota and its role in irritable bowel syndrome (IBS). Curr Gastroenterol Rep 15(5):323. https://doi.org/10.1007/s11894-013-0323-7
Partty A, Kalliomaki M (2017) Infant colic is still a mysterious disorder of the microbiota-gut-brain axis. Acta Paediatr 106(4):528–529. https://doi.org/10.1111/apa.13754
Partty A, Kalliomaki M, Endo A, Salminen S, Isolauri E (2012) Compositional development of Bifidobacterium and Lactobacillus microbiota is linked with crying and fussing in early infancy. PLoS One 7(3):e32495. https://doi.org/10.1371/journal.pone.0032495
Partty A, Lehtonen L, Kalliomaki M, Salminen S, Isolauri E (2015) Probiotic Lactobacillus rhamnosus GG therapy and microbiological programming in infantile colic: a randomized, controlled trial. Pediatr Res 78(4):470–475. https://doi.org/10.1038/pr.2015.127
Partty A, Kalliomaki M, Salminen S, Isolauri E (2017) Infantile colic is associated with low-grade systemic inflammation. J Pediatr Gastroenterol Nutr 64(5):691–695. https://doi.org/10.1097/MPG.0000000000001340
Perez-Burgos A, Wang L, McVey Neufeld KA, Mao YK, Ahmadzai M, Janssen LJ, Stanisz AM, Bienenstock J, Kunze WA (2015) The TRPV1 channel in rodents is a major target for antinociceptive effect of the probiotic Lactobacillus reuteri DSM 17938. J Physiol 593(17):3943–3957. https://doi.org/10.1113/JP270229
Rajilic-Stojanovic M, Biagi E, Heilig HG, Kajander K, Kekkonen RA, Tims S, de Vos WM (2011) Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 141(5):1792–1801. https://doi.org/10.1053/j.gastro.2011.07.043
Rigsbee L, Agans R, Shankar V, Kenche H, Khamis HJ, Michail S, Paliy O (2012) Quantitative profiling of gut microbiota of children with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol 107(11):1740–1751. https://doi.org/10.1038/ajg.2012.287
Romano C, Ferrau V, Cavataio F, Iacono G, Spina M, Lionetti E, Comisi F, Famiani A, Comito D (2014) Lactobacillus reuteri in children with functional abdominal pain (FAP). J Paediatr Child Health 50(10):E68–E71. https://doi.org/10.1111/j.1440-1754.2010.01797.x
Roos S, Dicksved J, Tarasco V, Locatelli E, Ricceri F, Grandin U, Savino F (2013) 454 pyrosequencing analysis on faecal samples from a randomized DBPC trial of colicky infants treated with Lactobacillus reuteri DSM 17938. PLoS One 8(2):e56710. https://doi.org/10.1371/journal.pone.0056710
Ruiz-Moyano S, Totten SM, Garrido DA, Smilowitz JT, German JB, Lebrilla CB, Mills DA (2013) Variation in consumption of human milk oligosaccharides by infant gut-associated strains of Bifidobacterium breve. Appl Environ Microbiol 79(19):6040–6049. https://doi.org/10.1128/AEM.01843-13
Sadeghzadeh M, Rabieefar A, Khoshnevisasl P, Mousavinasab N, Eftekhari K (2014) The effect of probiotics on childhood constipation: a randomized controlled double blind clinical trial. Int J Pediatr 2014:937212. https://doi.org/10.1155/2014/937212
Saulnier DM, Riehle K, Mistretta TA, Diaz MA, Mandal D, Raza S, Weidler EM, Qin X, Coarfa C, Milosavljevic A, Petrosino JF, Highlander S, Gibbs R, Lynch SV, Shulman RJ, Versalovic J (2011) Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology 141(5):1782–1791. https://doi.org/10.1053/j.gastro.2011.06.072
Savino F, Cordisco L, Tarasco V, Palumeri E, Calabrese R, Oggero R, Roos S, Matteuzzi D (2010) Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial. Pediatrics 126(3):e526–e533. https://doi.org/10.1542/peds.2010-0433
Savino F, Ceratto S, De Marco A, Cordero di Montezemolo L (2014) Looking for new treatments of Infantile Colic. Ital J Pediatr 40:53. https://doi.org/10.1186/1824-7288-40-53
Savino F, Garro M, Montanari P, Galliano I, Bergallo M (2018) Crying time and RORgamma/FOXP3 expression in lactobacillus reuteri DSM17938-treated infants with colic: a randomized trial. J Pediatr 192(171–177):e171. https://doi.org/10.1016/j.jpeds.2017.08.062
Schreck Bird A, Gregory PJ, Jalloh MA, Risoldi Cochrane Z, Hein DJ (2017) Probiotics for the treatment of infantile colic: a systematic review. J Pharm Pract 30(3):366–374. https://doi.org/10.1177/0897190016634516
Sghir A, Gramet G, Suau A, Rochet V, Pochart P, Dore J (2000) Quantification of bacterial groups within human fecal flora by oligonucleotide probe hybridization. Appl Environ Microbiol 66(5):2263–2266
Smith C, Nordstrom E, Sengupta JN, Miranda A (2007) Neonatal gastric suctioning results in chronic visceral and somatic hyperalgesia: role of corticotropin releasing factor. Neurogastroenterol Motil 19(8):692–699. https://doi.org/10.1111/j.1365-2982.2007.00949.x
Soares AC, Lederman HM, Fagundes-Neto U, de Morais MB (2005) Breath methane associated with slow colonic transit time in children with chronic constipation. J Clin Gastroenterol 39(6):512–515
Sung V, Hiscock H, Tang M, Mensah FK, Heine RG, Stock A, York E, Barr RG, Wake M (2012) Probiotics to improve outcomes of colic in the community: protocol for the Baby Biotics randomised controlled trial. BMC Pediatr 12:135. https://doi.org/10.1186/1471-2431-12-135
Sung V, Hiscock H, Tang ML, Mensah FK, Nation ML, Satzke C, Heine RG, Stock A, Barr RG, Wake M (2014) Treating infant colic with the probiotic Lactobacillus reuteri: double blind, placebo controlled randomised trial. BMJ 348:g2107. https://doi.org/10.1136/bmj.g2107
Sung V, D’Amico F, Cabana MD, Chau K, Koren G, Savino F, Szajewska H, Deshpande G, Dupont C, Indrio F, Mentula S, Partty A, Tancredi D (2018) Lactobacillus reuteri to treat infant colic: a meta-analysis. Pediatrics 141(1):e20171811. https://doi.org/10.1542/peds.2017-1811
Szajewska H, Gyrczuk E, Horvath A (2013) Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: a randomized, double-blind, placebo-controlled trial. J Pediatr 162(2):257–262. https://doi.org/10.1016/j.jpeds.2012.08.004
Tabbers MM, Chmielewska A, Roseboom MG, Crastes N, Perrin C, Reitsma JB, Norbruis O, Szajewska H, Benninga MA (2011) Fermented milk containing Bifidobacterium lactis DN-173 010 in childhood constipation: a randomized, double-blind, controlled trial. Pediatrics 127(6):e1392–e1399. https://doi.org/10.1542/peds.2010-2590
Tabbers MM, DiLorenzo C, Berger MY, Faure C, Langendam MW, Nurko S, Staiano A, Vandenplas Y, Benninga MA, European Society for Pediatric Gastroenterology H, Nutrition, North American Society for Pediatric G (2014) Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN. J Pediatr Gastroenterol Nutr 58(2):258–274. https://doi.org/10.1097/MPG.0000000000000266
Trivic I, Hojsak I (2018) Initial diagnosis of functional gastrointestinal disorders in children increases a chance for resolution of symptoms. Pediatr Gastroenterol Hepatol Nutr 21(4):264–270
Vandenplas Y, Gutierrez-Castrellon P, Velasco-Benitez C, Palacios J, Jaen D, Ribeiro H, Shek LP, Lee BW, Alarcon P (2013) Practical algorithms for managing common gastrointestinal symptoms in infants. Nutrition 29(1):184–194. https://doi.org/10.1016/j.nut.2012.08.008
Vulin K, Hojsak I (2015) Infantile colic – newer approach to an old problem. Lijec Vjesn 137(11–12):367–372
Walsham AD, MacKenzie DA, Cook V, Wemyss-Holden S, Hews CL, Juge N, Schuller S (2016) Lactobacillus reuteri inhibition of enteropathogenic Escherichia coli adherence to human intestinal epithelium. Front Microbiol 7:244. https://doi.org/10.3389/fmicb.2016.00244
Warschburger P, Hanig J, Friedt M, Posovszky C, Schier M, Calvano C (2014) Health-related quality of life in children with abdominal pain due to functional or organic gastrointestinal disorders. J Pediatr Psychol 39(1):45–54. https://doi.org/10.1093/jpepsy/jst070
Wegner A, Banaszkiewicz A, Kierkus J, Landowski P, Korlatowicz-Bilar A, Wiecek S, Kwiecien J, Gawronska A, Dembinski L, Czaja-Bulsa G, Socha P (2018) The effectiveness of Lactobacillus reuteri DSM 17938 as an adjunct to macrogol in the treatment of functional constipation in children. A randomized, double-blind, placebo-controlled, multiCenter trial. Clin Res Hepatol Gastroenterol 42:494. https://doi.org/10.1016/j.clinre.2018.03.008
Weizman Z, Abu-Abed J, Binsztok M (2016) Lactobacillus reuteri DSM 17938 for the management of functional abdominal pain in childhood: a randomized, double-blind, placebo-controlled trial. J Pediatr 174(160–164):e161. https://doi.org/10.1016/j.jpeds.2016.04.003
Wojtyniak K, Szajewska H (2017) Systematic review: probiotics for functional constipation in children. Eur J Pediatr 176(9):1155–1162. https://doi.org/10.1007/s00431-017-2972-2
Wojtyniak K, Horvath A, Dziechciarz P, Szajewska H (2017) Lactobacillus casei rhamnosus Lcr35 in the management of functional constipation in children: a randomized trial. J Pediatr 184(101–105):e101. https://doi.org/10.1016/j.jpeds.2017.01.068
Zhu L, Liu W, Alkhouri R, Baker RD, Bard JE, Quigley EM, Baker SS (2014) Structural changes in the gut microbiome of constipated patients. Physiol Genomics 46(18):679–686. https://doi.org/10.1152/physiolgenomics.00082.2014
Zoppi G, Cinquetti M, Luciano A, Benini A, Muner A, Bertazzoni Minelli E (1998) The intestinal ecosystem in chronic functional constipation. Acta Paediatr 87(8):836–841
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Hojsak, I. (2018). Probiotics in Functional Gastrointestinal Disorders. In: Guandalini, S., Indrio, F. (eds) Probiotics and Child Gastrointestinal Health. Advances in Experimental Medicine and Biology(), vol 1125. Springer, Cham. https://doi.org/10.1007/5584_2018_321
Download citation
DOI: https://doi.org/10.1007/5584_2018_321
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-14635-1
Online ISBN: 978-3-030-14636-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)